Concepedia

Author

Ivanka Toudjarska

Alnylam Pharmaceuticals (United States)

Also Known As

Ivanka Toudjarska

13

Publications

5.2K

Citations

8

H-Index

26

Concepts

All Affiliations

Alnylam Pharmaceuticals (United States)
IT

About

Ivanka Toudjarska is an author at Alnylam Pharmaceuticals (United States) specializing in engineering, medicine, and regenerative medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

2

2

1.2K

2

Medicine

2

2

155

3

Natural Sciences

1

1

144

4

Biomedical Engineering

1

1

1.2K

5

Biomolecular Engineering

1

1

1.2K

Ivanka Toudjarska

×

7

Publications

3K

Citations

7

H-Index

YearCitations

RNAi-mediated gene silencing in non-human primates

Tracy Zimmermann, Amy C. H. Lee, Akin Akinc,

Nature

2006

1.3K

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

Akin Akinc, Andreas Zumbuehl, Michael S. Goldberg,

Nature Biotechnology

2008

1.2K

RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy

Rene Alvarez, Sayda M. Elbashir, Todd Borland,

Antimicrobial Agents and Chemotherapy

2009

144

In vivo silencing of alpha-synuclein using naked siRNA

Jada Lewis, Heather L. Melrose, David Bumcrot,

Molecular Neurodegeneration

2008

143

Gene Silencing Activity of siRNAs with a Ribo-difluorotoluyl Nucleotide

Jie Xia, Anne M. Noronha, Ivanka Toudjarska,

ACS Chemical Biology

2006

83

A Recurring FBN1 Gene Mutation in Neonatal Marfan Syndrome

Amanda M. Jacobs, Ivanka Toudjarska, Andrew D. Racine,

Archives of Pediatrics and Adolescent Medicine

2002

46

Delivery of a Hammerhead Ribozyme Specifically Downregulates Mutant Type I Collagen mRNA in a Murine Model of Osteogenesis Imperfecta

Ivanka Toudjarska, Michael W. Kilpatrick, Junqi Niu,

Antisense and Nucleic Acid Drug Development

2001

11

Page 1